American Well Corporation
NYSE:AMWLMedical - Healthcare Information Services
+$0.24 today
- Market cap
- $171.77M
- Beta
- 1.70
- P/E (TTM)
- -1.6
- EPS (TTM)
- -$5.30
Volume 0.06M
Average 0.07M
AMWL Weighted Avg Shares (Diluted)
Average shares outstanding including dilutive securities, used to calculate diluted EPS.
American Well CorporationNYSE: AMWL
Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026
Weighted avg shares (diluted) grows in line with its trailing trend
Q1 FY2026 weighted avg shares (diluted) of 16.59M shares rose 5.9% year over year, behind the +6.6% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 1.2% from the prior quarter. Over 3 fiscal years it compounded at +5.4% a year.
Context
- Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +5.9% toward the trailing-twelve-month pace of +6.6%.
Sources:Income StatementText generated from reported figures; not investment advice.
Weighted Avg Shares (Diluted) history
Shares · from the income statement
- Latest · FY2025
- 16.05M USD
- Year-over-year change
- +7.0%
- 4-year CAGR
- +6.0%
| Period | Period end | Weighted Avg Shares (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 16.05M | +7.0% |
| FY2024 | 2024-12-31 | 15M | +5.5% |
| FY2023 | 2023-12-31 | 14.21M | +3.6% |
| FY2022 | 2022-12-31 | 13.71M | +7.9% |
| FY2021 | 2021-12-31 | 12.7M | — |
Weighted Avg Shares (Diluted) vs competitors
How AMWL compares with its peers on the latest reported figures
- AMWL's LTM Mar 2026 weighted avg shares (diluted) of 16.27M shares is the 7th highest of the 9 companies compared; the peer median is 45.72M shares.
- Its year-over-year change of +6.6% is the 8th highest of 9, against a peer median of +46.4%.
- Over three fiscal years its annual growth of +5.4% compares with a peer median of +45.6%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | 95.83M | +20.8% | +48.5% | |
| LTM Mar 2026 | 66.33M | +37.1% | +16.8% | |
| LTM Mar 2026 | 56.46M | +55.6% | +21.3% | |
| LTM Mar 2026 | 53.9M | +2.3% | +9.7% | |
| LTM Mar 2026 | 37.54M | +102.0% | — | |
| LTM Mar 2026 | 19.58M | +98.7% | +69.8% | |
| LTM Mar 2026 | 16.27M | +6.6% | +5.4% | |
| LTM Mar 2026 | 12.13M | +60.9% | +63.6% | |
| LTM Jun 2026 | 2.15M | +16.6% | +45.6% | |
| Peer median (excluding AMWL) | 45.72M | +46.4% | +45.6% | |
Competitors are the stored peer set for AMWL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 252.79M | 277.19M | 259.05M | 254.36M | 249.33M |
| Cost of Revenue | 148.47M | 160.42M | 164.29M | 155.41M | 116.47M |
| Gross Profit | 104.32M | 116.77M | 94.76M | 98.95M | 132.86M |
| Gross Margin | 41.3% | 42.1% | 36.6% | 38.9% | 53.3% |
| Research & Development | 106.59M | 138.49M | 105.83M | 86.07M | 72.86M |
| Selling, General & Admin | 160.78M | 227.98M | 213.11M | 197.45M | 131.31M |
| Operating Expenses | 283.46M | 392.62M | 786.9M | 316.49M | 238.13M |
| Depreciation & Amortization | 16.09M | 26.17M | 31.51M | 32.98M | 33.96M |
| EBITDA | (166.07M) | (245.84M) | (224.15M) | (176.91M) | (60.57M) |
| EBITDA Margin | -65.7% | -88.7% | -86.5% | -69.6% | -24.3% |
| Operating Income | (179.15M) | (275.85M) | (692.14M) | (217.53M) | (105.27M) |
| Operating Margin | -70.9% | -99.5% | -267.2% | -85.5% | -42.2% |
| Interest Income | 120K | 6.12M | 19.42M | 10.76M | 3.8M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (3.01M) | 3.85M | 16.83M | 7.65M | 10.74M |
| Income Before Tax | (182.16M) | (272.01M) | (675.31M) | (209.89M) | (94.53M) |
| Pre-Tax Margin | -72.1% | -98.1% | -260.7% | -82.5% | -37.9% |
| Income Tax Expense | (5.38M) | 64K | 3.86M | 2.75M | 434K |
| Net Income | (176.33M) | (270.43M) | (675.16M) | (208.14M) | (95.7M) |
| Net Margin | -69.8% | -97.6% | -260.6% | -81.8% | -38.4% |
| EPS (Basic) | (13.88) | (19.68) | (47.50) | (13.88) | (5.96) |
| EPS (Diluted) | (13.88) | (19.68) | (47.50) | (13.88) | (5.96) |
| Weighted Avg Shares | 12.7M | 13.71M | 14.21M | 15M | 16.05M |
| Weighted Avg Shares (Diluted) | 12.7M | 13.71M | 14.21M | 15M | 16.05M |
American Well Corporation
NYSE:AMWL
Intrinsic Alpha fair value
Locked
Current Price
$11.03
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.